DEXTROSE/VIOSER 5% w/v Solution for Infusion
Sponsors
Mediar Therapeutics Inc.
Conditions
Diffuse Cutaneous Systemic Sclerosis (dcSSc)Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
RecruitingCTIS2025-521278-32-00
Start: 2025-12-04Target: 58Updated: 2025-11-26
A Phase 2 Randomized, Double-blind, Placebo-Controlled Study to Assess the Safety and Efficacy of MTX-474 in the Treatment of Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Not yet recruitingCTIS2025-523288-39-00
Target: 3Updated: 2026-06-29